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Abstract
 .Phenolic antioxidants of the hydroxychroman class, a-tocopherol a-TOC and 2,2,5,6,7-pentamethyl-6-hydroxychro-
 . w x  .man PMHC , and the hindered phenols 2,3-dihydro-5-hydroxy-2,2,4-trimethylnaphtho 1,2-b furan NFUR , 2,6-di-tert-
 .  .  .butyl-4-methoxyphenol DBHA , and 2,6-di-tert-butyl-4-methyl phenol BHT , were delivered into oxidizable ACCEPTOR
 .  .liposomes of dilinoleoylphosphatidylcholine DLPC or 1-palmitoyl-2-linoleoyl-phosphatidylcholine PLPC from saturated
 .DONOR liposomes of dimyristoylphosphatidylcholine DMPC by liposomal transfer. The antioxidant activities, k , by theinh
inhibited oxygen uptake method were compared with the k s determined when the antioxidants were introduced into theinh
liposomes by coevaporation from organic solvents. The peroxidations were initiated using either thermal initiators,
 .  .water-soluble azo-bis-amidinopropane hydrochloride ABAP , lipid-soluble azo-bis-2,4-dimethylvaleronitrile ADVN and
 .di-tert-butylhyponitrite DBHN , or the photoinitiator benzophenone. The antioxidants PMHC, NFUR, DBHA, and BHT
transferred rapidly between liposomes, but several hours of incubation were needed to transfer a-TOC. The average k s ininh
liposomes, in the relative order NFUR,DBHA)PMHC)BHT,a-TOC, were markedly lower than known values in
organic solvent. k values in liposomes appear to be controlled by effects of hydrogen bonding with water and byinh
restricted diffusion of antioxidants, especially in the case of a-TOC. Product studies of the hydroperoxides formed during
 .inhibited oxygen consumption were carried out. The cis,transrtrans,trans c,trt,t product ratios of the 9- and 13-hydro-
peroxides formed from PLPC during inhibited peroxidation by PMHC were similar for both the coevaporated and liposomal
transfer procedures. The c,trt,t ratio for the same concentration of a-TOC, 1.52, compares to a value of 1.69 for PMHC at
the start of the inhibition period. The higher c,trt,t ratio observed for NFUR in DLPC, which varied between values of 7.0
at the start of the inhibition to about 1.8 after the break in the induction period, is a reflection of the increased hydrogen
atom donating ability of the antioxidant plus the increased concentration of oxidizable lipid provided by DLPC. q 1997
Elsevier Science B.V.
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1. Introduction
Antioxidants are of continuing interest for their
ability to protect the unsaturated lipids of biological
0005-2736r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
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membranes from oxidative damage, and thus have
been the subject of many scientific papers and re-
 w x.views e.g., 1–9 . Without protection, such oxida-
tive damage can lead to tissue damage and various
pathological events. Model membrane systems are
commonly used to study antioxidant behaviour pre-
liminary to monitoring their behaviour in a native
membrane, where the membrane proteins and the
variety of lipid types can complicate the study. It has
been shown that the classical kinetic methods of
autoxidation and antioxidant action in solution are
applicable to studies in model phospholipid mem-
w xbranes 10,11 . Uninhibited autoxidation of phospho-
lipid membranes follows the free-radical mechanism
 .  .presented in Eqs. 1 – 4 , initiated in this example by
an azo-initiator.
Initiation:
k i
R–N5N–R “ 2RPqN , ratesR 1 .2 i
Propagation:
fastRPqO “ ROOP 2 .2
k p
ROOPqRH “ ROOHqRP 3 .
Termination:
2 k t
ROOPqROOP “ non-radical productsqO 4 .2
The rate law for this mechanism is presented in Eq.
 .5 :
1r2 1r2yd O rd tsk r 2k RH R 5 . .2 p t i
where k represents the propagation rate constant,p
w x2k the termination rate constant, RH the substratet
concentration, and R , the rate of chain initiation. Byi
using an azo-initiator with known properties, it is
  ..possible to control the R Eq. 6 , which is veryi
important for quantitative studies.
R s2 ek R–N5N–R 6 .i i
The quantity e is the efficiency of the initiator, and
k is its decomposition rate constant.i
When a phenolic antioxidant is added to a system
undergoing autoxidation, the antioxidant molecules
can trap peroxyl radicals formed during the propaga-
 .  .tion step, as represented in Eqs. 7 and 8 :
k inhibitor
ArOHqROOP “ ArOPqROOH 7 .
fastArOPqROOP “ ArOROO 8 .
As a result, oxygen uptake is suppressed until the
antioxidant is consumed. This inhibition period, t ,
has a simple relationship to the R , and thus the Ri i
 .can be calculated using Eq. 9 :
R sn ArOH rt 9 .i
where n is the stoichiometric factor for the antioxi-
dant, the measure of how many peroxyl molecules
are trapped per antioxidant molecule.
Using a steady-state approximation, the rate law
for suppressed oxygen uptake during inhibition Eq.
 ..10 :
yd O rd tsk rk RH R r 2 ArOH 10 . .2 p inh i
can be expressed in terms of the R , the substrate andi
antioxidant concentrations, and the rate constants for
propagation, k , and inhibition, k .p inh
Studies on antioxidant activity in liposomes typi-
cally use the process of coevaporation to introduce
lipid-soluble antioxidants into a model membrane,
combining the desired antioxidant, phospholipids, and
lipid-soluble initiator in an organic solvent to ensure
mixing, followed by removal of the solvent and
preparation of the liposome in a selected buffer.
There are, however, certain limitations associated
with the coevaporation technique, namely:
 .1 When initiator and inhibitor are both present in
a sample, there is usually some loss of both during
sample preparation, hampering quantitative kinetic
studies.
 .2 Time is required for the sample to reach the
temperature of the surrounding water bath and for the
rate of initiator decomposition to establish itself, and
w xthis initial lag period must be taken into account 10 .
 .3 One cannot introduce a lipid-soluble antioxi-
dant into a natural cell membrane for study if coevap-
oration is the only way to deliver it, because the
normal organization and behaviour of the cell mem-
brane’s phospholipids and proteins would be de-
stroyed by the coevaporation process.
 .4 Using the coevaporation procedure, each sam-
ple preparation would provide only one inhibition
period for kinetic study.
In a preliminary study, we found that the use of
intermembrane transfer to deliver antioxidants insolu-
ble or sparingly soluble in water avoided some of
w xthese limitations 12 . Although little has been re-
ported on the application of this method to deliver
( )L.R.C. Barclay et al.rBiochimica et Biophysica Acta 1328 1997 1–12 3
Fig. 1. Antioxidants used to study transfer of lipid-soluble anti-
oxidants from DMPC to DLPC liposomes.
w xantioxidants 13–16 , many report using liposomes as
carriers for therapeutic drugs in animals and humans
w x17–25 , a process which probably involves similar
transfer phenomena between hydrophobic phases.
We now present a detailed quantitative study on
the efficiency of intermembrane transfer of anti-
oxidants. In order to study intermembrane transfer,
known concentrations of the lipid soluble anti-
 .oxidants a-tocopherol a-TOC , 2,2,5,6,7-penta-
 .methyl-6-hydroxychroman PMHC , 2,6-di-tert-
 .butyl-4-methoxyphenol DBHA , 2,6-di-tert-butyl-4-
 .methyl phenol BHT or the naphthofuran derivative,
w2,3-dihydro-5-hydroxy-2,2,4-trimethylnaphtho 1,2-
x  .  .b furan NFUR Fig. 1 were prepared in saturated
liposomes of dimyristoylphosphatidylcholine DMPC,
.DONOR-liposomes . These DONOR-liposomes were used
to inhibit peroxidation reactions in unsaturated lipo-
somes of dilinoleoyl-phosphatidylcholine DLPC, AC-
.CEPTOR-liposomes , initiated by either the water-solu-
ble azo-initiator azo-bis-amidinopropane hydrochlo-
 .ride ABAP , the lipid-soluble ones azo-bis-2,4-di-
 .methylvaleronitrile ADVN and di-tert-butyl-
 .hyponitrite DBHN , or the photoinitiator benzo-
phenone.
The effect on the peroxidation of unsaturated bi-
layers of these two methods to deliver the anti-
oxidants, liposomal transfer and coevaporation, are
 .compared by: 1 the profiles of suppressed oxygen
 .uptake; 2 the resulting antioxidant activities, k ;inh
 .and 3 the effect on the linoleate hydroperoxides
formed during peroxidation inhibited by PMHC and
NFUR, compared to these products formed in the
presence of a-TOC. In addition, a study is made of
the time-profile to transfer a-TOC between DONOR
and ACCEPTOR liposomes.
The antioxidant activities, k s , were determinedinh
by measuring the oxygen uptake during the course of
inhibition periods. The results are applied to the
 .integrated form of the inhibition equation, Eq. 11 ,
w xas used before 10 :
D O syk rk RH ln 1y trt 11 .  .2 p inht
The k is obtained from a plot of the linear equa-inh
w x  .tion, D O vs. yln 1y trt , where the slope is2 t
w xequal to k RH rk . The k value used for DLPCp inh p
y1 y1 w xin bilayers is 36.1 mol s 10 .
2. Materials and methods
2.1. Materials
The phospholipids DLPC, DMPC and 1-palmi-
 .toyl-2-linoleoyl-phosphatidylcholine PLPC were
purchased from Avanti Polar Lipids and stored at
y308C in sealed vials.
Phosphate buffer was prepared using 0.05 M
NaH PO , 0.05 M Na HPO , and 0.1 mM Na EDTA2 4 2 4 2
in water obtained from a Millipore Milli-Q Plus
Ultrapure Water System. The pH was adjusted to 7.0
using HCl. Traces of heavy metal were removed by
passing the prepared buffer through a column of
 .Chelex 100, 50–100 mesh Bio Rad . PMHC was
w xprepared using a known procedure 26 . a-TOC,
DBHA, and BHT were purchased from Aldrich.
Trolox C was a gift from Hoffman-Laroche Nutley,
.NJ, USA . The NFUR was a gift from Dr. Kazuo
 .Mukai Ehime University, Matsuyama, Japan . ABAP
was purchased from Polysciences Inc. ADVN was
also purchased from Polysciences Inc. and was re-
crystallized from methanol before use, m.p. 70–728C
 w x.lit. value 75–768C 27 . DBHN was synthesized
w xusing a known procedure 28 , and the purity of the
product was checked using thin layer chromatogra-
phy. Benzophenone was purchased from Anachemia.
2.2. Autoxidation procedure
A sensitive pressure transducer system, described
w xpreviously 29 , was used to monitor autoxidations at
378C, under oxygen at 760 Torr. Antioxidants were
introduced to the liposomes either using the coevapo-
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ration method during liposome preparation or else via
direct transfer from a DONOR liposome of DMPC. In
the coevaporation method, antioxidant and initiator
were added in solution to an oxidizable substrate
 .DLPC in methanol. The solvent was then removed
under reduced pressure, and the liposomes were pre-
pared in buffer using freeze–thaw cycles in liquid
nitrogen. For direct transfer, the antioxidant was co-
 .evaporated into an unoxidizable DONOR lipid DMPC
and prepared as a separate liposome from the initia-
torrDLPC liposome. When oxidation of the DLPC
was underway, a known volume of the DONOR antiox-
idantrDMPC was added to the DLPC liposome.
 .  .Both multilamellar MLV and unilamellar ULV
vesicles were used in these studies. In most experi-
ments, unilamellar liposomes were prepared from
w xmultilamellar liposomes using an extruder 30 . In
one series of experiments, unilamellar liposomes were
also prepared by passing multilamellar liposomes
w xthrough a French pressure cell 31 . Corrections for
‘lag time’ in the start of autoxidation experiments
were made using a previously published procedure
w x10 . For one series of experiments, a film of dry
PMHC was shaken with buffer at 378C for 7 h to
partially dissolve the PMHC. Concentration of the
PMHC in the buffer was determined using ultraviolet
 .  y1 y1.UV analysis at 292 nm es3071 mol cm to
be 1.93=10y4 M. The solubility of DBHN in buffer
was studied by adding buffer to a film of dry DBHN
in a reaction cell and shaking it at 378C for 30 min.
The concentration of DBHN in buffer was deter-
 y1mined using UV analysis at 227 nm es5954 mol
y1. y4cm to be 2.13=10 M. For some experiments,
DBHN was prepared in solutions of known concen-
tration in tert-butyl alcohol and added in a small
volume to prepared DLPC or antioxidantrDLPC li-
posomes in the autoxidation apparatus. No delay in
initiation of the DLPC oxidation was seen when the
DBHN was added in solution. Trolox was prepared in
solutions of known concentration in buffer and stored
at 58C for up to 2 weeks. Solutions of other in-
hibitors, initiators, and substrates were kept in the
dark at y108C for up to 1 week.
2.3. Hydroperoxide analyses
To obtain a profile of hydroperoxide analysis dur-
ing the course of inhibited peroxidation, two experi-
ments were performed on the same liposome prepara-
tion. In the first experiment, the profile and length of
 .the inhibition period t were determined. In the
parallel experiment, samples were withdrawn from
the mixture at known intervals along the inhibition
period using a precision evacuated syringe. Samples
were immediately reduced in 1.0 ml of 10 mM
triphenylphosphine in methanol and vortex mixed 20
seconds. A 1.5-ml volume of 0.45 M KOH in
methanol was added and the sample was vortexed
again for 20 s. The sample was left at room tempera-
ture for 15 min, then 1.0 ml 1.0 M NH Cl in water4
was added and the sample was vortexed for a final 20
s. Two 1.0-ml hexane extractions were carried out,
and the hexane layers were combined and condensed
under argon to approximately 200 ml.
The samples were analysed using an HP1050
HPLC with a Hibar LiChrosorb Si60, 5-mm, 4 mm
= 25 cm column. The elution solvent contained
4:4:992 acetoner2-propanolrhexane. Peaks were de-
tected using the HP1050 internal variable wavelength
detector at 234 nm interfaced with a computer for
calculations. Using a flow rate of 1.6 mlrmin the
product isomers eluted as follows: 13 c,t — 16.9
min; 13 t,t — 19.5 min; 9 c,t — 23.9 min; 9 t,t —
26.6 min. The peak areas were corrected for the
known molar absorptivities of each isomer and the
w xratios calculated as before 31 .
2.4. a-tocopherol analyses
Transfer of a-TOC from DONOR DMPC to ACCEP-
TOR DLPC liposomes required that the liposomes be
shaken together at 378C for prolonged periods under
argon. Samples were removed from the mixture prior
to initiation of DLPC oxidation to analyse the amount
of a-TOC remaining in the total sample DMPCq
.DLPC . To extract the a-TOC, 500 ml of sample
were vortex mixed with 1.0 ml 0.5 M SDS for 30 s
and then 1.0 ml methanol for 30 s to break up the
liposomes. Two 2.0-ml hexane extractions were car-
ried out to remove the a-TOC from the mixture, the
extracts were separated by centrifugation in a bench-
top centrifuge, and the hexane layers were combined
and condensed to a known volume, to which was
added an internal standard, benzophenone. The sam-
ples were analysed using an HP1050 HPLC with a
Hibar LiChrosorb Si60, 5-mm, 4 mm = 25 cm
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column. The elution solvent contained 1:99 2-pro-
panolrhexane. Peaks were detected using the HP1050
internal variable wavelength detector at 290 nm. Us-
ing a flow rate of 0.5 mlrmin, the benzophenone
eluted at 7.7 min and the a-TOC at 9.9 min.
2.5. NMR spectra of liposomes
The nature of the liposome preparations was con-
firmed by 31P-NMR spectra on samples prepared in
THAM buffer, pH 7.0. Spectra were measured on a
JEOL 270 MHZ Spectrometer using pulse sequences
Fig. 2. A. Profiles of PMHC inhibited oxidation of DLPC
 .liposomes comparing the liposomal transfer method T with the
 .coevaporation method C ; initiation by ABAP added in buffer. U
 .
— uninhibited oxidation of DLPC; C — 17.05 nmol PMHC c ,
6.50=10y6 mol ABAP, 5.66=10y5 mol DLPC, the extended
 .induction period is attributed to a lag time see text ; T — 21.11
 . y6 y5nmol PMHC t , 6.22=10 mol ABAP, 8.90=10 mol DLPC,
R s4.56=10y12 mol sy1.i
B. Profiles of a-TOC inhibited oxidation of DLPC liposomes to
present qualitative differences when the antioxidant is incubated
 .  .for 2 h T2 or 5 h T5 to allow transfer of the antioxidant from
DMPC to DLPC liposomes before the initiation. Initial amount of
a-TOC added in DMPC was 53.36 nmol. DLPC oxidation was
initiated with ABAP added in buffer. U — uninhibited oxidation
of DLPC; T2 — 28.70 nmol a-TOC 53.8% transferred after 2-h
. y6 y5incubation , 3.70=10 mol ABAP, 4.29=10 mol DLPC,
y12 y1 R s4.20=10 mol s ; T5 — 52.76 nmol a yTOC 98.9%i
. y6transferred after 5-h incubation , 3.71=10 mol ABAP, 4.29=
10y5 mol DLPC, R s4.21=10y12 mol sy1.i
Fig. 3. Profiles of PMHC inhibited oxidation of DLPC liposomes
 .comparing the liposomal transfer method T with the coevapora-
 .tion method C ; initiation by coevaporated ADVN. U — unin-
 .hibited oxidation of DLPC; C — 15.00 nmol PMHC c , 3.17
mmol ADVN, 5.76=10y5 mol DLPC, R s2.98=10y12 moli
y1  . y5s ; T — 9.44 nmol PMHC t , 2.83 mmol ADVN, 7.43=10
mol DLPC, R s1.90=10y12 mol sy1.i
w xreported before 31 . The MLV particles exhibited
typical broad chemical shift anisotropies of 45–50
ppm, whereas the liposomes prepared using the ex-
truder or French press exhibited single narrow
w xisotropic lines characteristic of ULV liposomes 31 .
3. Results
3.1. Peroxidation initiated by the water-soluble
initiator, ABAP
An advantage of using a water-soluble initiator is
that it can be introduced after liposome preparation.
We observed, however, a delay in obtaining a con-
stant rate of oxygen uptake after ABAP was added to
the liposomes. When an antioxidant is already present
 .coevaporated , this delay becomes part of the inhibi-
tion period, resulting in large errors in determining
  ..the R using Eq. 9 and the k . This effect isi inh
attributed to the inhomogeneity of the MLV system
w x12,32 , whereby ABAP does not diffuse immediately
through all layers of the membrane to initiate new
peroxyl chain reactions in a uniform manner. Conse-
quently, whenever feasible, the oxygen uptake was
allowed to reach a constant rate, signifying a constant
R , before an inhibitor was added. Under this condi-i
tion, the R , calculated from the known e and k fori i
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Table 1
Specific and average antioxidant activities of phenolic antioxidants in DLPC liposomes undergoing ABAP-initiated oxidation at 378C —
ABAP was added to the DLPC liposomes in buffer a
b c d eArOH CrT DLPC ABAP R n k Average ki inh inh
5 12 y1 y4 y1 y1 y4 y1 y1 .  .  .  .  .  .nmol 10 mol mmol 10 mol s 10 M s 10 M s
f .1 PMHC 16.89 T 5.55 6.45 4.46 18–36 0.98 1.14"0.30
 .2 PMHC 15.86 T 5.66 6.26 4.80 19–39 0.98 1.04"0.21
 .3 DBHA 11.45 T 4.29 3.55 3.82 10–27 1.43 1.50"0.18
g .4 a-TOC 26.60 C 4.29 3.71 2.59 35–62 0.28 0.28–0.29
h g .5 a-TOC 53.36 T 4.28 3.71 2.59 22–45 0.40
h g .6 a-TOC 53.36 T 4.29 3.71 2.59 13–26 0.34
a  .Amounts are expressed as moles for comparison purposes between tables since the initiators ABAP and DBHN Table 3 are introduced
in the aqueous phase. The k are reported as My1 sy1 assuming that inhibition is entirely in the lipid phase of the bilayers.inh
b Cscoevaporated in DLPC; Ts transferred from DMPC liposomes.
c  . w xR was calculated based upon the induction period using R sn moles inhibitor rt , where ns2 for DBHA and PMHC 10 .i i
d w x w x . w x  .  .The kinetic chain length during the inhibition period, calculated from the equation ns O y O rn AH 1y trt ln 1y trt2 t 2 ts0 0
w x10 .
e  .  .  .Number of experiments averaged: 1 3 , 2 10 , 3 10 . Line 4 is from 2 experiments.
f PMHC was transferred from buffer.
g w xThe R was calculated using the expression R s2 ek ABAP .i i i
h  g.  .Using the t of the transfer runs, the R value footnote , and the expression R sn moles inhibitor rt , the moles of a-TOCi i
 .transferred from DMPC to DLPC liposomes were calculated. In line 5, 28.7 nmol a-TOC 54% transferred after 2-h incubation. In line
 .6, 52.8 nmol a-TOC 99% transferred after 5-h incubation.
  . y6ABAP Eq. 6 , es0.43 and k s1.32=10 moli
y1 w x.s 33 , agrees with the R calculated from thei
  ..induction period Eq. 9 .
Typical profiles of oxygen uptake for ABAP-ini-
tiated peroxidation of DLPC liposomes, inhibited by
 .PMHC coevaporated and transferred and by a-TOC
 .transferred after incubation , are illustrated in Fig. 2.
These profiles show that PMHC provides effective
inhibition immediately upon injection of the DONOR
DMPC liposomes. Similar results were observed for
transfer of DBHA and NFUR from DONOR DMPC
 .liposomes not shown . Transfer of a-TOC, however,
 .required rather long incubation times 2–5 h before
 .effective inhibition occurred vide infra . Detailed
data for reactions initiated by ABAP and inhibited by
these antioxidants are given in Table 1. Satisfactory
Table 2
Specific and average antioxidant activities of phenolic antioxidants in DLPC liposomes undergoing ADVN-initiated oxidation at 378C —
ADVN was coevaporated into the DLPC liposomes a
b c d eArOH CrT DLPC ADVN R n k Average ki inh inh
5 12 y1 y4 y1 y1 y4 y1 y1 .  .  .  .  .  .nmol 10 mol mmol 10 mol s 10 M s 10 M s
 .1 PMHC 15.00 C 5.76 3.17 2.98 15–38 0.90 1.16"0.28
 .2 PMHC 24.10 T 14.90 2.88 2.97 17–35 1.22 1.49"0.32
 .3 DBHA 16.6 C 11.25 3.03 2.51 10–47 2.16 1.95"0.46
f .4 DBHA 5.73 T 15.00 3.21 2.51 35–94 1.92 1.87"0.63
g .5 NFUR 16.83 C 15.00 3.32 2.64 20–56 1.73 1.42"0.24
g .6 NFUR 23.80 T 14.88 2.61 2.48 12–42 2.24 2.04"0.83
a – d See Table 1.
e  .  .  .  .  .  .Number if experiments averaged: 1 5 , 2 13 , 3 8 , 4 3 , 5 3 , 6 8 .
f  .In comparison, the k value for transferred DBHA obtained using the lipid-soluble photo-initiator benzophenone was 2.39"0.28 =inh
4 y1 y1  .10 M s 9 experiments .
g R was measured using PMHC inhibition in the same experiment.i
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w x  .linear plots of D O vs. yln 1y trt were ob-2 t
tained for these antioxidants and the k valuesinh
obtained are included in Table 1.
3.2. Peroxidation initiated by the lipid-soluble initia-
tor, ADVN
The lipid-soluble azo-initiator ADVN has been
frequently used to initiate peroxidation inside the
w xlipid phase of bilayers 2,10,31,32 . In these experi-
ments the initiator must be introduced by the usual
coevaporation method along with the lipid vide in-
.fra . The antioxidant activities of PMHC, DBHA, and
NFUR, introduced by liposomal transfer, were com-
pared to the values obtained when they were coevap-
orated along with the ADVN and DLPC. Fig. 3
shows typical profiles of suppressed oxygen uptake
when introducing PMHC by the two methods. The
PMHC appears as effective when introduced by lipo-
somal transfer as by coevaporation. Similar results
 .were obtained using DBHA and NFUR not shown .
Summaries of the antioxidant activities, k , deter-inh
mined for PMHC, DBHA, and NFUR introduced by
the two methods are given in Table 2. The results
show that the two delivery methods give similar
values for the k s within experimental error, al-inh
though the values using the liposomal transfer method
appear marginally higher. Results when peroxidation
was photochemically initiated with benzophenone and
inhibited with transferred DBHA are included for
 e.comparison purposes Table 2, footnote .
Attempts were made to initiate peroxidation of
DLPC by transferring ADVN from DONOR DLPC
liposomes. Very long ‘lag times’ were observed be-
fore oxygen uptake was obtained for both MLV and
ULV DLPC, thus this method seems unsatisfactory
for quantitative studies.
3.3. Peroxidations initiated by DBHN — Initiator
efficiency
Earlier studies reported advantages in the use of
 .di-tert-butylhyponitrite DBHN for initiation of per-
w xoxidation in liposomes 34 . To avoid loss of DBHN,
which occurs when it is introduced by coevaporation,
it was added to prepared liposomes in buffer where
it was found to be soluble to 2.13=10y4 M concen-
.trations or in small volumes of tert-butyl alcohol.
Both methods of introducing DBHN gave immediate
and controlled uptake of oxygen. The experimental
traces, including inhibition by BHT, shown in Fig. 4,
are characteristic of these results. Summaries from
inhibition studies employing PMHC, NFUR, and BHT
under these conditions are given in Table 3.
The efficiency of initiation by azo-initiators is
known to be diminished in solvents of high viscosity
due to their effects on cage recombination. This is
especially true for initiation in the hydrophobic phase
of PC bilayers due to their high microviscosity. Thus
the efficiency of DBHN when coevaporated into egg
lecithin bilayers decreased to only 9.1% from 66% in
w xchlorobenzene 34 . We found that the efficiency of
DBHN when introduced to DLPC from tert-butyl
alcohol was substantially greater than when it was
coevaporated. The average value of e, determined
using the induction period method with PMHC,
DBHA, and BHT over the concentration range of
 .DBHN used Table 3 , is 30"3%; more than three
Table 3
Specific and average antioxidant activities of phenolic antioxidants in DLPC liposomes undergoing DBHN-initiated oxidation at 378C —
DBHN was added in buffer or tert-butyl alcohol to the DLPC liposomes a
b c d eArOH CrT DLPC DBHN R n k Average ki inh inh
5 12 y1 y4 y1 y1 y4 y1 y1 .  .  .  .  .  .nmol 10 mol mmol 10 mol s 10 M s 10 M s
f .1 PMHC 3.54 T 5.12 0.25 0.72 29–79 1.18 0.96"0.30
f g .2 NFUR 3.54 T 5.12 0.22 0.73 43–75 2.60 1.94"0.64
 .3 BHT 23.39 C 5.18 1.01 4.33 23–42 0.33 0.46"0.16
 .4 BHT 23.38 T 5.18 0.89 5.56 16–38 0.45 0.48"0.04
a – d See Table 1.
e  .  .  .  .Number of experiments averaged: 1 5 , 2 6 , 3 3 , 4 5 .
f DBHN was added in buffer, otherwise the DBHN was added in tert-butyl alcohol.
g R was measured using DBHA inhibition in the same experiment.i
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times that found when DBHN is coevaporated into
w xbilayers 34 . This value is similar to that found in
w x0.50 M SDS, which is 29% 35 .
( )3.4. Transfer of a-TOC between DONOR DMPC and
( )ACCEPTOR DLPC liposomes
To determine the antioxidant activity of a-TOC
 .Section 3.1 , it was necessary to estimate the amount
transferred between DMPC and DLPC liposomes.
Previous studies have shown that the phytyl side
chain of a-TOC affects its antioxidant activity in
w xmodel systems 36 , which could account for its slow
w xtransport from a protein to a lipid membrane 37 or
w xbetween liposomes 12 . An estimate of the amount
of a-TOC transferred to oxidizable DLPC liposomes
was made by incubating samples under nitrogen of
 .  .a-TOCrDMPC DONOR with DLPC ACCEPTOR li-
 .posomes for various periods. Samples 2.0 ml were
removed and oxidized by initiation with DBHN, us-
ing the procedure outlined in Section 3.3. The amount
of a-TOC transferred to the DLPC liposomes was
 . w xcalculated using Eq. 9 , ArOH sR rnt , by mea-i
suring the inhibition period and calculating the R i
 . using Eq. 6 using the known e and k for DBHNi
.under these conditions . Results of this latter study
are outlined in Fig. 5. This procedure was applied
successfully to study transfer of a-TOC to ULV
Fig. 4. Profiles of BHT inhibited oxidation of DLPC liposomes
 .comparing the liposomal transfer method T with the coevapora-
 .tion method C ; initiation by DBHN in tert-butyl alcohol. U —
 .uninhibited oxidation of DLPC; C — 23.39 nmol BHT c , 1.02
mmol DBHN, 5.18=10y5 mol DLPC, R s6.43=10y12 moli
y1  . y5s ; T — 23.38 nmol BHT t , 0.93 mmol DBHN, 5.18=10
mol DLPC, R s6.48=10y12 mol sy1.i
Fig. 5. Percent of total moles of a-TOC transferred from DMPC
liposomes to unilamellar and multilamellar DLPC liposomes with
shaking at 378C under argon for various incubation periods. The
w xpercent transfer was calculated using the relationship ArOH s
R rnt , where the R was determined using the initiator DBHNi i
delivered in tert-butyl alcohol. ’ — DLPC liposomes were
prepared with 0.05 M THAM buffer, pH 7.0, and made unilamel-
lar by the extruder or French press method. The two measure-
ments at 5 h represent typical error limits. v — multilamellar
DLPC liposomes were prepared with 0.1 M phosphate buffer, pH
7.0.
DLPC but satisfactory inhibition periods were not
observed using MLV DLPC.
3.5. Profiles of product analyses of linoleate
hydroperoxides during uninhibited and inhibited
peroxidation
The hydroperoxides formed during controlled per-
oxidation of linoleate chains provide very important
information on the mechanism of lipid peroxidation
and the action of inhibitors. In particular, pioneering
research by Porter et al. showed that the cis,trans to
 .trans,trans c,trt,t ratio of the geometrical isomers of
the hydroperoxides formed at the 9- and 13- positions
of the linoleate chain bear a simple linear relationship
to the hydrogen atom donating ability of the medium
w x38,39 . The c,trt,t ratio during inhibited oxidation of
model membranes was earlier found to be affected
 . w xe.g., raised by an antioxidant such as a-TOC 40 .
We have found it useful to use this ratio to monitor
the effect of antioxidants such as a-TOC and Trolox
on DLPC liposomes under different methods of initi-
w xation 41 .
The present work starts with examining peroxida-
tion of bilayers of 1-palmitoyl-2-linoleoyl-
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 .phosphatidylcholine PLPC , which has only one un-
saturated acyl chain. Hydroperoxide product results
from PLPC are not expected to be complicated by a
mixture of intramolecular or ‘arm-to-arm’ propaga-
w xtion 42 along with intermolecular propagation, which
w xcan affect the c,trt,t ratios 43 .
The hydroperoxides formed were reduced with
triphenylphosphine to alcohols which were analysed
as their corresponding methyl esters by HPLC. The
c,trt,t ratios formed during uninhibited, DBHN-ini-
tiated peroxidation of PLPC bilayers remained con-
stant at 0.59"0.01 from 1% to 5% oxidation, the
maximum percent oxidation in our kinetic and prod-
uct studies. On the other hand, the c,trt,t ratio in-
creases linearly as the concentration of a-TOC in the
bilayer increases, as shown in Fig. 6. This serves as a
useful ‘standard plot’ for comparison with the hydro-
peroxide ratios formed when peroxidation is inhibited
by other antioxidants.
The variations in c,trt,t ratios of the linoleate
hydroperoxides formed during inhibition by PMHC,
for the two methods of delivery, are illustrated in Fig.
 .  .7A coevaporated and 7B liposomal transfer for
the DBHN-initiated peroxidation of PLPC.
Similar experiments were carried out to measure
the profiles of c,trt,t ratios for DLPC liposomes
when liposomal transfer of an antioxidant was used
 .to inhibit oxidation again DBHN-initiated . For ex-
Fig. 6. Plot of changing c,trt,t product ratios with increasing
concentration of a-tocopherol in PLPC. PLPC amounts ranged
from 2.98=10y5 to 3.40=10y5 mol. Oxidation was initiated
with 1.14=10y6 mol DBHN in tert-butyl alcohol. The error bar
represents average error.
Fig. 7. A. Profile of inhibited oxygen uptake during PMHC
inhibited oxidation of PLPC, showing changing c,trt,t product
 y8 .ratios during the inhibition. PMHC 3.756=10 mol was
 y5 .coevaporated into the PLPC liposomes 5.25=10 mol PLPC .
Oxidation of PLPC was initiated by DBHN in tert-butyl alcohol
 y6 .3.17=10 mol . The error bar represents average error.
B. Profile of inhibited oxygen uptake of PMHC inhibited oxida-
tion of PLPC, showing changing c,trt,t product ratios during the
 y8 .inhibition. PMHC 8.729=10 mol was transferred from
 y5 .DMPC into the PLPC liposomes 5.25=10 mol PLPC . Oxi-
dation of PLPC was initiated by DBHN in tert-butyl alcohol
 y6 .2.99=10 mol . The error bar represents average error.
ample, transfer into DLPC of 0.523 mM NFUR
showed c,trt,t ratios which varied from 7.26 at the
start of the inhibition to 1.81 after the break in the
induction period. At the same concentration of a-TOC
in PLPC, the c,trt,t ratio was 1.25 at the start of the
 .inhibition Fig. 6 .
4. Discussion
The profiles of inhibited oxygen uptake obtained
by liposomal transfer demonstrate the remarkable
usefulness of this method to deliver antioxidants to
 .bilayers. The results show Figs. 2–4 that liposomal
transfer gives immediate inhibition of peroxidation
without the disadvantages shown by the more time-
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consuming coevaporation methods commonly used to
deliver lipid-soluble antioxidants. This means that
compounds like PMHC, DBHA, BHT and NFUR
must pass the water–lipid barrier between liposomes
and diffuse readily through each layer of the MLV
system to provide efficient inhibition throughout the
bilayer. This is not surprising since PMHC was found
earlier to pass through a dialysis membrane and
distribute between liposomes on both sides of this
w xbarrier 12 . It is anticipated that this method of
delivery of antioxidants will prove very useful to
explore antioxidant action in natural lipid systems of
biological membranes.
The introduction of DBHN in small amounts of
tert-butyl alcohol 10–15 ml in a 2.00-ml liposome
.volume has been found to have some advantages
over other methods of initiation, the main one being
the absence of the delays or ‘lag times’ in reaching
constant oxygen uptake found with water-soluble
 .ABAP added after liposome preparation and with
lipid-soluble ADVN added to liposomes by coevap-
.oration . The increased efficiency observed for DBHN
30% when introduced in tert-butyl alcohol vs. 9.1%
.when coevaporated into the bilayer phase was unex-
pected. It implies that DBHN undergoes appreciable
decomposition in the aqueous phase rather than in the
bilayer. The resulting tert-butoxyl radicals,
 .CH C–OP , are expected to readily cross the wa-3 3
ter–lipid barrier and initiate reaction by H-atom ab-
straction. Methylperoxyl radicals could also form due
to expected b-cleavage of tert-butoxyl radicals
w xformed in the polar aqueous phase 44 and rapid
oxidation of the derived methyl radicals. Such de-
rived methylperoxyl radicals might also contribute to
the initiation process, although this is less likely
w xwhen DBHN is thermolyzed inside the bilayer 34 .
The quantitative kinetic method, using a known
and controlled R , is a very reliable one to determinei
antioxidant activities. The absolute inhibition rate
constants, k s , based on measurements of suppressedinh
oxygen uptake by phosphatidylcholine membranes
are determined to within 30% error. All known meth-
ods to measure k s have uncertainties unless it isinh
known that the radical derived from the antioxidant
does not continue the oxidation chain either directly
w xby H-atom abstraction 45 or addition to a multiple
bond, or indirectly after addition to O to form a new2
peroxyl radical. This ‘prooxidant effect’ may become
significant in heterogeneous systems of isolated lipid
w xparticles compared to solution 46–55 . In addition,
lipid particle size is recognized as important in the
balance between pro- and antioxidant effects of a-
w xTOC 47–49 . Our system of bilayers may be suscep-
tible to such prooxidant effects so that comparisons
with data in homogeneous solution are made with
some reservation. Nevertheless it is significant to find
remarkable differences in k s determined in lipo-inh
somes compared to known, reliable values in homo-
geneous solution also determined using the sensitive
w xinhibited oxygen uptake method 56 . In homoge-
neous solution the k values obtained for a-TOC,inh
PMHC and BHT were 320=104, 380=104 and
4 y1 y1 w x1.4=10 M s , respectively 56 , and for NFUR
4 y1 y1 w x2870=10 M s 57 . Our current study in
liposomes shows that the order of antioxidant activi-
ties of the hydroxychromans is NFUR)PMHC)a-
TOC. Thus the superior activity of NFUR found in
w x w xsolution 57 and micelles 58 is carried over to lipid
membranes. However, there are marked effects of
these aqueous systems on the activities. The most
pronounced effect is observed with a-TOC which
gives an antioxidant activity about three orders of
magnitude less in DLPC liposomes than in solution.
The k of PMHC also drops by a factor of aboutinh
300. On the other hand the ‘effect’ on BHT results in
a decrease by a factor of only 3. In other words, we
find the k of BHT to be similar to a-TOC ininh
bilayers, whereas a-TOC is at least 200 times more
w xactive in solution 56 .
Quantitative explanations for the diminution of
antioxidant k in aqueous dispersions were giveninh
earlier in terms of hydrogen bonding at the phenolic
w xhydroxyl and para ether oxygen by water 10,59,60 .
Later it was shown that the latter effect is not signifi-
w xcant in reducing the k of a-TOC 61 . Recentinh
important quantitative studies have been carried out
on solvent effects for abstraction of the phenolic
w x w xhydrogen from a-TOC 62 and analogues 63 which
concluded that most of the diminution in antioxidant
activity of a-TOC in bilayers is due to it being
 .‘physically inaccessible’ to the lipid peroxyl radi-
cals, and only a small fraction of the k wasinh
w xaffected by hydrogen bonding by water 63 . The
activities of antioxidants of the vitamin E class in
aqueous dispersions of bilayers are thus controlled by
a combination of hydrogen bonding and restricted
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diffusion of lipid peroxyls and antioxidants in the
bilayer region. We found the latter effect to be most
pronounced for a-TOC as an extended mixing time,
perhaps as long as 9 to 10 h, was required to transfer
 .most of the a-TOC between liposomes Fig. 5 ,
whereas the smaller more mobile compounds like
PMHC appear to transfer rapidly between bilayers
under the same conditions. These differences must be
kept in mind when designing experiments for testing
the behaviour of different antioxidants which include
a-TOC on natural systems.
Studies of the 9- and 13-hydroperoxides formed
from linoleate chains during inhibited oxygen con-
sumption provide further information useful for com-
paring the effectiveness of different antioxidants. For
example, PLPC oxidation, when inhibited by coevap-
orated PMHC, shows a c,trt,t ratio of 1.69 at the
start of the inhibition period, compared to a ratio of
 .1.52 for the same concentration of a-TOC Fig. 6 .
This is another way of showing the more efficient
action of PMHC than a-TOC in this model system.
The profile of the c,trt,t ratio for transferred PMHC
 .during the corresponding inhibition period Fig. 7B
is much ‘flatter’ than that for the coevaporated case
 .Fig. 7A . This may simply reflect the higher initial
concentration of PMHC, 1.62 M, in the transfer study
compared to 0.75 M in the coevaporation study. The
higher c,trt,t ratios observed for NFUR in DLPC is a
reflection of two factors contributing to increased
hydrogen atom donating ability, the increased sub-
strate concentration provided by the dual chain sys-
tem and the higher antioxidant activity provided by
NFUR. We plan to estimate antioxidant activities by
employing quantitative studies of c,trt,t ratios and
will report on this separately.
Acknowledgements
This research was supported by the Natural Sci-
ences and Engineering Research Council of Canada
with Research Grants to L.R.C.B., an International
Scientific Exchange Award to K.M., and by a grant
from the Japan Science and Technology Fund.
L.R.C.B. was a recipient of a JSPS Fellowship for
Research in Japan. F.A. received a travel grant from
PRAXIS XXI.
References
w x  .1 L.R.C. Barclay, Can. J. Chem. 71 1993 1–16.
w x  .2 E. Niki, Chem. Phys. Lipids 44 1987 227–253.
w x  .3 G.W. Burton, K.U. Ingold, Acc. Chem. Res. 19 1986
194–201.
w x4 B. Halliwell, J.M.C. Gutteridge, Free Radicals in Biology
and Medicine. Clarendon Press, Oxford, 1985.
w x  .5 W.A. Pryor Ed. , Free Radicals in Biology, vols. I–V,
Academic Press, New York, 1976–1982.
w x  .6 H. Sies Ed. , Oxidative Stress, Academic Press, New York,
1985.
w x7 Proc. Symp. Biol. Oxid. Syst., San Diego, CA, Academic
Press, New York, 1990.
w x  .8 W.A. Pryor, S.S. Godber, Free Radic. Biol. Med. 10 1991
177–184.
w x  .9 L.R. Mahoney, Angew. Chem. Int. Edit. 8 1969 547–555.
w x10 L.R.C. Barclay, K.A. Baskin, K. Dakin, S.J. Locke, M.R.
 .Vinqvist, Can. J. Chem. 68 1990 2258–2269.
w x11 L.R.C. Barclay, S.J. Locke, J.M. MacNeil, J. VanKessel,
 .G.W. Burton, K.U. Ingold, J. Am. Chem. Soc. 106 1984
2479–2481.
w x12 L.R.C. Barclay, K.A. McLaughlin, M.R. Vinqvist, J. Lipo-
 .some Res. 5 1995 955–979.
w x  .13 Y. Nakagawa, S. Nojima, K. Inoue, J. Biochem. 87 1980
497–502.
w x14 V.E. Kagan, R.A. Bakalova, Zh.Zh. Zhelev, D.S. Rangelova,
E.A. Serbinova, V.A. Tyurin, N.K. Denisova, L. Parker,
 .Arch. Biochem. Biophys. 280 1990 147–152.
w x15 L.J. Smith, J. Anderson, M. Shamsuddin, Am. Rev. Respir.
 .Disease 145 1992 153–159.
w x16 K. Werninghaus, R.M. Handjani, B.A. Gilchrest, Photo-
 .derm. Photoimmun. Photomed. 8 1991 236–242.
w x17 T.J. McIntosh, S.A. Simon, P. Vierling, C. Santaella, Y.
 .Ravily, Biophys. J. 71 1996 1853–1868.
w x  .18 R.T. Mehta, Antimicrob. Agents Chemother. 40 1996
1893–1902.
w x  .19 H. Harashima, H. Kiwada, Adv. Drug Deliv. Rev. 19 1996
425–444.
w x  .20 E. Tomlinson, A.P. Rolland, J. Controlled Release 39 1996
357–372.
w x21 H.B. Arnardottin, S.J. Sveinsson, T. Kristmundsdottir, Int. J.
 .Pharmac. 134 1996 71–77.
w x  .22 J.E. Diederichs, Electrophoresis 17 1996 607–611.
w x23 K. Kobayashi, M. Han, S. Watarai, T. Yasuda, Acta Medica
 .Okayama 50 1996 67–72.
w x24 G. Blume, A. Schatzlein, D. Gebauer, A. Paul, Adv. Drug
 .Deliv. Rev. 18 1994 349–378.
w x25 J.A.A.M. Kamps, P.J. Swart, H.W.M. Morselt, R. Pauwels,
M.P. Debethune, E. Declercq, D.K.F. Meijer, G.L. Scher-
 .phof, Biochim. Biophys. Acta — Biomemb. 1278 1996
183–190.
w x26 L.I. Smith, H.E. Ungnade, H.H. Hoehn, S. Wawzonek, J.
 .Org. Chem. 4 1939 311–317.
w x27 C.G. Overberger, M.B. Berenbaum, J. Am. Chem. Soc. 73
 .1951 2618–2621.
( )L.R.C. Barclay et al.rBiochimica et Biophysica Acta 1328 1997 1–1212
w x  .28 G.D. Mendenhall, Tetrahedron Lett. 24 1983 451–452.
w x29 D.D.M. Wayner, G.W. Burton, Handbook of Free Radicals
and Antioxidants in Biomembranes, vol. III, CRC Press,
Boca Raton, FL, 1989, pp. 223–232.
w x30 M.J. Hope, R. Nayar, L.D. Mayer, P.R. Cullis, in: G.
 .Gregoriadis Ed. , Liposome Technology, vol. I, CRC Press,
Boca Raton, FL, 1992.
w x31 L.R.C. Barclay, K.A. Baskin, D. Kong, S.J. Locke, Can. J.
 .Chem. 65 1987 2541–2550.
w x32 T. Doba, G.W. Burton, K.U. Ingold, Biochim. Biophys.
 .Acta 835 1985 298–303.
w x33 L.R.C. Barclay, M.R. Vinqvist, Free Radic. Biol. Med. 16
 .1994 779–788.
w x  .34 L.R.C. Barclay, K.U. Ingold, J. Am. Chem. Soc. 103 1981
6478–6485.
w x35 L.R.C. Barclay, S.J. Locke, J.M. MacNeil, Can. J. Chem. 63
 .1985 366–374.
w x36 E. Niki, A. Kamakami, M. Saito, Y. Yamamoto, J. Tsuchiya,
 .Y. Kamiya, J. Biol. Chem. 260 1985 2191–2196.
w x37 L.R.C. Barclay, A.M.H. Bailey, D. Kong, J. Biol. Chem.
 .260 1985 15809–15814.
w x  .38 N.A. Porter, Acc. Chem. Res. 19 1986 262–268.
w x  .39 N.A. Porter, D.G. Wujek, J. Am. Chem. Soc. 106 1984
2626–2629.
w x  .40 H. Weenen, N.A. Porter, J. Am. Chem. Soc. 104 1982
5216–5221.
w x41 L.R.C. Barclay, J.D. Artz, J.J. Mowat, Biochim. Biophys.
 .Acta 1237 1995 77–85.
w x  .42 V.W. Bowry, J. Org. Chem. 59 1994 2250–2252.
w x43 F. Antunes, A., Salvador, R.E. Pinto, private communica-
tion, Grupo de Bioquimica e Biologia Teoricas, Instituto de´
Investigac¸ao Cientifica da Rocha Cabral, Cc¸. Bento da˜
Rocha Cabral, 14, P-1250 Lisboa, Portugal.
w x44 D.V. Avila, C.E. Brown, K.U. Ingold, J. Lusztyk, J. Am.
 .Chem. Soc. 115 1993 466–470.
w x45 M. Foti, K.U. Ingold, J. Lusztyk, J. Am. Chem. Soc. 116
 .1994 9440–9447.
w x46 A. Kontush, B. Finckh, B. Karten, A. Kohlschutter, U.¨
 .Beisiegel, J. Lipid Res. 37 1996 1436–1448.
w x47 K.U. Ingold, V.W. Bowry, R. Stocker, C. Walling, Proc.
 .Natl. Acad. Sci. USA 90 1993 45–49.
w x  .48 V.W. Bowry, R. Stocker, J. Am. Chem. Soc. 115 1993
6029–6044.
w x49 V.W. Bowry, K.U. Ingold, R. Stocker, Biochem. J. 288
 .1992 341–344.
w x50 Y. Yoshida, J. Tsuchiya, E. Niki, Biochem. Biophys. Acta
 .1200 1994 85–92.
w x51 N.M. Storozhok, N.O. Pirogov, S.A. Krashakov, N.G.
 .Khrapova, E.B. Burlakova, Kinet. Catal. 36 1995 751–756.
w x52 M. Takahashi, Y. Yoshikawa, E. Niki, Bull. Chem. Soc.
 .Jpn. 62 1989 1885–1890.
w x  .53 K. Yamamoto, E. Niki, Biochim. Biophys. Acta 958 1988
19–23.
w x  .54 Z-L. Liu, L-J. Wang, Y-C. Liu, Sci. China, B 34 1991
787–795.
w x55 S. Nagaoka, Y. Oauchi, S. Urano, U. Nagashima, K. Mukai,
 .J. Am. Chem. Soc. 112 1990 8921–8924.
w x56 G.W. Burton, T. Doba, E.J. Gabe, L. Hughes, F.L. Lee, L.
 .Prasad, K.U. Ingold, J. Am. Chem. Soc. 107 1985 7053–
7065.
w x57 L.R.C. Barclay, M.R. Vinqvist, K. Mukai, S. Itoh, H.
 .Morimoto, J. Org. Chem. 58 1993 7416–7420.
w x58 L.R.C. Barclay, C.D. Edwards, K. Mukai, Y. Egawa, T.
 .Nishi, J. Org. Chem. 60 1995 2739–2744.
w x59 L.R.C. Barclay, K.A. Baskin, S.J. Locke, T.D. Schaefer,
 .Can. J. Chem. 65 1987 2529–2540.
w x60 W.A. Pryor, T. Strickland, D.F. Church, J. Am. Chem. Soc.
 .110 1988 2224–2229.
w x61 M. Iwatsuki, J. Tsuchiya, E. Komuro, Y. Yamamoto, E.
 .Niki, Biochim. Biophys. Acta 1200 1994 19–26.
w x62 L. Valgimigli, J.T. Banks, K.U. Ingold, J. Lusztyk, J. Am.
 .Chem. Soc. 117 1995 9966–9971.
w x63 L. Valgimigli, K.U. Ingold, J. Lusztyk, J. Am. Chem. Soc.
 .118 1996 3545–3549.
